The Asia-Pacific injection pen market is anticipated to grow at a CAGR of 8.1% over the forecast period (2020-2026). The key factors that drive the growth of the injection pen industry in the Asia-Pacific region include the huge population and a large pool of diabetic patients in the region. As per the World Bank 2020, China is the second-largest economy after the US and has the world’s largest population of approximately 1.4 billion, followed by India of approximately 1.3 billion.
Browse the full report description of "Asia-Pacific Injection Pen Market Size, Share & Trends Analysis Report by Type (Reusable and Disposable), by Disorder Type (Autoimmune Disorder, Hormonal Disorders, Orphan Disease, and Others), and Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/asia-pacific-injection-pen-market
Both economies hold nearly 40.0% of the total world population share. The United Nations Population Division projects that India’s population aged 50 years and older will reach 34.0% by 2050. Whereas, Beijing State Council Information Office projected that China’s aged population (above 60 years old) will reach 255 million by 2020. With a rise in the population along with the age dynamics, there is an increased chance of incidences of diabetes in the Asia-Pacific, which is expected to increase the market growth.
Market Coverage
Key questions addressed by the report
Asia-Pacific Injection Pen Market – Segmentation
By Type
By Disorder Type
Asia-Pacific Injection Pen Market – Countries Covered